HealthStream Analyst Price Targets

HealthStream Inc

HSTMNASDAQ

Trade with Public

$33.13

-0.62-1.84%

마지막 업데이트: Oct 16, 4:18 PM

$33.10

-0.65-1.93%

개요 뉴스 실적 전망목표가재무 심리 지분 현황 배당금 비교 옵션 주식 보고서

HealthStream Analyst Price Targets

Wall Street analyst price targets and consensus rating for HealthStream (HSTM).

Price Target Range — 9 Quarters

Analyst Consensus — 4 Analysts

1Buy

3Hold

Consensus RatingHold# Analysts4Avg. Consensus PT$32Upside to Avg. PT-2.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 13, 2026	Freedom Capital Markets	Gene Mannheimer	Initiate	Hold	$36
Jul 21, 2026	Canaccord Genuity	Richard Close	PT Raise	Hold	$24→$27
May 6, 2026	Canaccord Genuity	Richard Close	PT Raise	Hold	$21→$24
Dec 17, 2025	Canaccord Genuity	Richard Close	Maintained	Hold	$28
Aug 7, 2025	Canaccord Genuity	Richard Close	PT Cut	Hold	$29→$28
May 15, 2025	Canaccord Genuity	Richard Close	PT Cut	Hold	$30→$29
Feb 26, 2025	Canaccord Genuity	Richard Close	PT Raise	Hold	$29→$30
Feb 6, 2025	JMP Securities	Constantine Davides	Maintained	Market Perform	—
Oct 23, 2024	Barclays	—	PT Raise	Overweight	$32→$34
Oct 23, 2024	Canaccord Genuity	Richard Close	PT Raise	Hold	$28→$29
Jul 24, 2024	Canaccord Genuity	Richard Close	PT Raise	Hold	$27→$28
Dec 6, 2023	JMP Securities	Constantine Davides	Initiate	Market Perform	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Freedom Capital Markets Initiates Coverage On HealthStream with Hold Rating, Announces Price Target of $36

Freedom Capital Markets analyst Gene Mannheimer initiates coverage on HealthStream (NASDAQ:HSTM) with a Hold rating and announces Price Target of $36.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $27

Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and raises the price target from $24 to $27.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $24

Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and raises the price target from $21 to $24.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on HealthStream, Maintains $28 Price Target

Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and maintains $28 price target.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $28

Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and lowers the price target from $29 to $28.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $29

Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and lowers the price target from $30 to $29.

Benzinga Newsdesk

HealthStream Inc

HealthStream Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Freedom Capital Markets Initiates Coverage On HealthStream with Hold Rating, Announces Price Target of $36

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $27

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $24

PRO
Canaccord Genuity Maintains Hold on HealthStream, Maintains $28 Price Target

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $28

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $29

뉴스

파트너 / 기고자

벤징가 글로벌

HealthStream Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Freedom Capital Markets Initiates Coverage On HealthStream with Hold Rating, Announces Price Target of $36

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $27

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $24

PRO
Canaccord Genuity Maintains Hold on HealthStream, Maintains $28 Price Target

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $28

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $29

People Also Watch

People Also Watch

HealthStream Inc

HealthStream Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROFreedom Capital Markets Initiates Coverage On HealthStream with Hold Rating, Announces Price Target of $36

PROCanaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $27

PROCanaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $24

PROCanaccord Genuity Maintains Hold on HealthStream, Maintains $28 Price Target

PROCanaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $28

PROCanaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $29

뉴스

파트너 / 기고자

벤징가 글로벌

HealthStream Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROFreedom Capital Markets Initiates Coverage On HealthStream with Hold Rating, Announces Price Target of $36

PROCanaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $27

PROCanaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $24

PROCanaccord Genuity Maintains Hold on HealthStream, Maintains $28 Price Target

PROCanaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $28

PROCanaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $29

People Also Watch

People Also Watch

PRO
Freedom Capital Markets Initiates Coverage On HealthStream with Hold Rating, Announces Price Target of $36

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $27

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $24

PRO
Canaccord Genuity Maintains Hold on HealthStream, Maintains $28 Price Target

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $28

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $29

PRO
Freedom Capital Markets Initiates Coverage On HealthStream with Hold Rating, Announces Price Target of $36

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $27

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $24

PRO
Canaccord Genuity Maintains Hold on HealthStream, Maintains $28 Price Target

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $28

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $29